MONOPAR THERAPEUTICS INC (MNPR) Stock Income Statement
NASDAQ:MNPR - US61023L2079 - Common Stock
44.21 USD
+5.37 (+13.83%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 19.11M | 16.00M | 8.83M | 10.54M | 9.13M | |||
| Research and Development | 14.28M | N/A | 5.60M | 7.59M | 6.49M | |||
| Selling, General, and Administrative Expenses | 4.82M | 3.16M | 3.23M | 2.95M | 2.63M | |||
| Operating Income | -19.11M | -16.00M | -8.83M | -10.54M | -9.13M | |||
| Interest Income/Expense | 1.63M | N/A | 429.00K | 20.00K | 20.00K | |||
| Other Income/Expense | N/A | 170.00K | N/A | N/A | 0.00 | |||
| Income Before Taxes | -17.31M | -16.00M | -8.40M | -10.52M | -9.10M | |||
| Net Income | -17.31M | -16.00M | -8.40M | -10.52M | -9.10M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.33 | -4.22 | -3.04 | -0.83 | -0.73 | |||
| Non GAAP EPS | -3.85 | -4.12 | -3.05 | -4.15 | -3.70 | |||
| Statistics | ||||||||
All data in USD